18F-FTX

N/A

Report date: 2025/11/27 15:48:10

NME

Base Information

Drug Name18F-FTX

Drug Alias Name[18F]fluorotamoxifen18F-FTX[18F]FTX

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionEstrogen receptors binders

TargetsEstrogen receptors

Therapy Area/IndicationsUterine Cervical NeoplasmsBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Texas MD Anderson Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center

Inactive CompaniesN/A

Active IndicationsUterine Cervical NeoplasmsBrain Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A